<DOC>
	<DOCNO>NCT01522716</DOCNO>
	<brief_summary>The aim study evaluate safety efficacy mesenchymal stromal cell treatment steroid-refractory chronic graft-versus-host disease .</brief_summary>
	<brief_title>Mesenchymal Stromal Cells Treatment Chronic Graft-versus-host Disease</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Chronic graftversushost disease , grade moderate severe despite least 3 month treatment calcineurin inhibitor steroids OR Chronic graftversushost disease , grade moderate severe , full treatment calcineurin inhibitor steroids impossible due intolerable sideeffects Active malignancy Fulfilling criterion previously initiate study treatment chronic graftversushost disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>